A new federal policy bans the use of federal grants to distribute life-saving drug test strips to the public, sparking concerns of increased overdoses in cities like Baltimore, where mass overdose incidents have occurred in recent years.
In Baltimore, the Harm Reduction Coalition has been distributing test strips to identify harmful adulterants like fentanyl and benzodiazepines, which can increase the risk of overdose when combined with opioids. The strips have been credited with saving lives, but the new policy could limit their availability.
Drug Test Strips
The Substance Abuse and Mental Health Services Administration has prohibited the use of federal grants for distributing test strips and other harm reduction practices, citing concerns that they “facilitate illicit drug use and are incompatible with Federal laws.” However, health advocacy groups argue that the strips have been used for nearly 10 years to identify adulterants and have been credited with saving lives.
The policy exception allows federal funds to be used to purchase test strips for law enforcement officers, public health officials, and medical professionals, but not for distribution to the public. This has raised concerns among health advocates, who point to evidence that giving test strips to people who use drugs can change behavior and reduce the risk of overdose.
According to Yngvild Olsen, a former official with the Substance Abuse and Mental Health Services Administration, there is a substantial body of evidence that shows giving test strips to people who use drugs can lead to behavioral changes, such as deciding not to use the substance or taking precautions like carrying naloxone.
Implications and Reactions
The new policy has been met with criticism from health advocacy groups, who argue that it will increase the risk of overdoses and undermine efforts to address the opioid crisis. Baltimore Mayor Brandon Scott has spoken out against the policy, highlighting the importance of harm reduction practices in reducing overdose deaths.
The policy shift has significant implications for cities like Baltimore, where the opioid crisis has had a devastating impact. As the federal government focuses on other techniques, such as distributing naloxone, health advocates are left wondering what the consequences will be for those who rely on test strips to stay safe.
The decision to ban federal funds for drug test strips has broader significance, as it reflects a shifting approach to addressing the opioid crisis, one that prioritizes treatment and recovery over harm reduction and prevention. As the crisis continues to evolve, it remains to be seen how this policy will impact communities already struggling to cope with the devastating consequences of addiction.
